Kimble Jenkins's most recent trade in ClearPoint Neuro Inc was a trade of 547 Common Stock done at an average price of $5.7 . Disclosure was reported to the exchange on Sept. 30, 2020.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ClearPoint Neuro Inc | Kimble Jenkins | Director | Grant, award, or other acquisition of securities at price $ 5.71 per share. | 30 Sep 2020 | 547 | 49,043 (0%) | 0% | 5.7 | 3,123 | Common Stock |